Anti-inflammatory effect of the endocannabinoid anandamide in experimental periodontitis and stress in the rat

NeuroImmunoModulation

Volumn 19, Issue 5, 2012, Pages 293-303

  Rettori, Elisa ^a,b   De Laurentiis, Andrea ^b   Zorrilla Zubilete, Mara ^b   Rettori, Valeria ^b   Elverdin, Juan Carlos ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

Bone loss; Corticosterone; Cytokines; Immobilization stress; Molar ligature; Nitric oxide; Prostaglandin E

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; ANTIINFLAMMATORY AGENT; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CORTICOSTERONE; INTERLEUKIN 1BETA; NITRIC OXIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMOBILIZATION STRESS; INHIBITION KINETICS; LOCOMOTION; MALE; NONHUMAN; ORGAN WEIGHT; OSTEOLYSIS; PERIODONTITIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; WEIGHT GAIN; WESTERN BLOTTING;

ALVEOLAR BONE LOSS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARACHIDONIC ACIDS; BODY WEIGHT; CANNABINOID RECEPTOR AGONISTS; CORTICOSTERONE; DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXPLORATORY BEHAVIOR; INDOLES; INTERLEUKIN-1BETA; MALE; NITRIC OXIDE SYNTHASE; PERIODONTITIS; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PROSTAGLANDINS E; PYRAZOLES; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC; STRESS, PSYCHOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863530790     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000339113     Document Type: Article

References (44)

1. Haffajee AD, Socransky SS: Microbial etio-logical agents of destructive periodontal diseases. Periodontol 2000 1994; 5:78-111.
2. Dye BA: Global periodontal disease epide-miolog y. Periodontol 2000 2012; 58: 10-25.
3. Romanelli H, Gonzalezy Rivas M, Chiappe V, Gómez M, Macchi R: Periodontal treatment needs in Argentine adult subjects. Acta Odontol Latinoam 2007; 20: 39-47.
4. Stashenko P, Jandinski JJ, Fujiyoshi P, Rynar J, Socransk y SS: Tissue levels of bone resorp-tive cytokines in periodontal disease. J Peri-odontol 1991; 62: 504-509.
5. Koide M, Kinugawa S, Takahashi N, Udaga-wa N: Osteoclastic bone resorption induced by innate immune responses. Periodontol 2000 2010; 54: 235-246.
6. Berglundh T, Donati M: Aspects of adaptive host response in periodontitis. J Clin Peri-odontol 2005; 32(suppl 6):87-107. (Pubitemid 41391059)
7. Genco RJ: Current view of risk factors for periodontal diseases. J Periodontol 1996; 67: 1041-1049. (Pubitemid 126613084)
8. Breivik T, Thrane PS, Murison R, Gjermo P: Emotional stress effects on immunity, gingivitis and periodontitis. Eur J Oral Sci 1996; 104:327-334. (Pubitemid 126782179)
9. Genco RJ, Ho AW, Grossi SG, Dunford RG, Tedesco LA: Relationship of stress, distress, and inadequate coping behaviors to peri-odontal disease. J Periodontol 1999; 70: 711-723.
10. Boyapati L, Wang HL: The role of stress in periodontal disease and wound healing. Periodontol 2000 2007; 44: 195-210.
11. Gaspersic R, Stiblar-Martincic D, Skaleric U: Influence of restraint stress on ligature-induced periodontitis in rats. Eur J Oral Sci 2002; 110:125-129.
12. Struillou X, Boutigny H, Soueidan A, Layrolle P: Experimentalanimal models in periodontology: a review. Open Dent J 2010; 4: 37-47.
13. Di Paola R, Mazzon E, Muià C, Crisafulli C, Terrana D, Greco S, Britti D, Santori D, Oteri G, Cordasco G, Cuzzocrea S: Effects of etan-ercept, a tumour necrosis factor-alpha antagonist, in an experimental model of peri-odontitis in rats. Br J Pharmacol 2007; 150: 286-297. (Pubitemid 46221038)
14. Verzeletti GN, Gaio EJ, Rösing CK: Effect of methotrexate on alveolar bone loss in experimental periodontitis in Wistar rats. Acta Odontol Scand 2007; 65:348-351. (Pubitemid 350249167)
15. Ugar-Cankal D, Ozmeric N: A multifaceted molecule, nitric oxide in oral and periodontal diseases. Clin Chim Acta 2006; 366:90-100. (Pubitemid 43330970)
16. Queiroz-Junior CMF, Pacheco CM, Maltos KLM, Caliari MV, Duarte IDG, Francischi JN: Role of systemic and local administration of selective inhibitors of cyclo-oxygen-ase 1 and 2 in an experimental model of peri-odontal disease in rats. J Periodontal Res 2009; 44: 153-160.
17. Howlet AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ: Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 2004; 47:345-358. (Pubitemid 39298276)
18. Weidenfeld J, Feldman S, Mechulam R: Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypo-thalamo-pituitary- adrenal axis in the rat. Neuroendocrinology 1994; 59: 110-112. (Pubitemid 24032705)
19. Wenger T, Jamali KA, Juaneda C, Leonardel-li J, Tramu G: Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus. Biochem Biophys Res Commun 1997; 237: 724-728. (Pubitemid 27434755)
20. Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ: Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 2004; 145:5431-5438. (Pubitemid 39564580)
21. Pandey R, Mousawy K, Nagarkatti M, Na-garkatti P: Endocannabinoids and immune regulation. Pharmacol Res 2009; 60:85-92.
22. Prestifilippo JP, Fernández-Solari J, de la Cal C, Iribarne M, Suburo AM, Rettori V, Mc-Cann SM, Elverdin JC: Inhibition of salivary secretion by activation of cannabinoid receptors. Exp Biol Med (Maywood) 2006; 231: 1421-1429. (Pubitemid 44330578)
23. Nakajima Y, Furuichi Y, Biswas KK, Hashi-guchi T, Kawahara K, Yamaji K, Uchimura T, Izumi Y, Maruyama I: Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-KB pathway inhibition. FEBS Lett 2006; 580: 613-619. (Pubitemid 43089695)
24. Kozono S, Matsumaya T, Bisawa KK, Kawahara K, Nakajima Y, Yoshimoto T, Yonamine Y, Kadomatsu H, Tancharoen S, Hashiguchi T, Noguchi K, Maruyama I: Involvement of the endocannabinoid system in periodontal healing. Biochem Biophys Res Commun 2010; 394: 928-933.
25. Prut L, Belzung C: The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003; 463:3-33. (Pubitemid 36205070)
26. Faletti A, Perez Martinez S, Perotti C, de Gi-meno MA: Activity of ovarian nitric oxide synthase (NOS) during ovulatory process in the rat: relationship with prostaglandins (PGs) production. Nitric Oxide 1999; 3: 340-347. (Pubitemid 29406762)
27. Bredt DS, Snyder SH: Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990; 87:682-685.
28. Sallay K, Sanavi F, Ring I, Pham P, Behling UH, Nowotny A: Alveolar bone destruction in the immunosuppressed rat. J Periodontal Res 1982; 17: 263-274. (Pubitemid 13228052)
29. De Laurentiis A, Fernandez-Solari J, Mohn C, Burdet B, Zorrilla Zubilete MA, Rettori V: The hypothalamic endocannabinoid system participates in the secretion of oxytocin and tumor necrosis factor-alpha induced by lipo-polysaccharide. J Neuroimmunol 2010; 221: 32-41.
30. Xie R, Kuijpers-Jagtman AM, Maltha JC: Inflammatory responses in two commonly used rat models for experimental tooth movement: comparison with ligature-induced periodontitis. Arch Oral Biol 2011; 56: 159-167.
31. Kuhr A, Popa-Wagner A, Schmoll H, Schwahn C, Kocher T: Observations on experimental marginal periodontitis in rats. J Periodontal Res 2004; 39:101-106. (Pubitemid 39090090)
32. Klausen B: Microbiological and immunolog-ical aspects of experimental periodontal disease in rats: a review article. J Periodontol 1991; 62: 59-73.
33. Breivik T, Sluyter F, Hof M, Cools A: Differential susceptibility to periodontitis in genetically selected Wistar rat lines that differ in their behavioral and endocrinological response to stressors. Behav Genet 2000; 30: 123-130. (Pubitemid 30660644)
34. Kinane DF, Preshaw PM, Loos BG: Host-response: understanding the cellular and molecular mechanisms of host-microbial interactions-consensus of the Seventh European Workshop on Periodontology. J Clin Peri-odontol 2011; 38(suppl 11):44-48.
35. Breivik T, Gundersen Y, Myhrer T, Fonnum F, Osmundsen H, Murison R, Gjermo P, von Hörsten S, Opstad PK: Enhanced susceptibility to periodontitis in an animal model of depression: reversed by chronic treatment with the anti-depressant tianeptine. J Clin Periodontol 2006; 33:469-477. (Pubitemid 43937630)
36. O'Connor TM, O'Halloran DJ, Shanahan F: The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to mela ncholia. QJM 2000; 93: 323-333. (Pubitemid 30386803)
37. Romeo HE, Tio DL, Rahman SU, Chiappelli F, Taylor AN: The glossopharyngeal nerve as a novel pathway in immune-to-brain communication: relevance to neuroimmune surveillance of the oral cavity. J Neuroimmunol 2001; 115: 91-100. (Pubitemid 32245657)
38. Besedovsky HO, del Rey A: Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 1996; 17:64-102. (Pubitemid 26061368)
39. Györfi A, Fazekas A, Rosivall L: Neurogenic inflammation and the oral mucosa. J Clin Periodontol 1992; 19: 731-736.
40. Pradeep AR, Raj S, Aruna G, Chowdhry S: Gingival crevicular fluid and plasma levels of neuropeptide substance-P in periodontal health, disease and after nonsurgical therapy. J Periodonta l Res 2009; 44: 232-237.
41. Larsen PJ, Jessop D, Patel H, Lightman SL, Chowdrey HS: Substance P inhibits the release of anterior pituitary adrenocorticotro-phin via a central mechanism involving corticotrophin-releasing factor-containing neurons in the hypothalamic paraventricu-lar nucleus. J Neuroendocrinol 1993; 5: 99-105. (Pubitemid 23189176)
42. McEwen BS: Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 2008; 583: 174-185.
43. Ziegler CG, Mohn C, Lamounier-Zepter V, Rettori V, Bornstein SR, Krug AW, Ehrhart-Bornstein M: Expression and function of en-docannabinoid receptors in the human adrenal cortex. Horm Metab Res 2010; 42:88-92.
44. Napimoga MH, Benatti BB, Lima FO, Alves PM, Campos AC, Pena-Dos-Santos DR, Se verino FP, Cunha FQ, Guimarães FS: Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats. Int Immuno-pharmacol 2009; 9: 216-222.